BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31425813)

  • 21. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results.
    Kühn JP; Hernando D; Muñoz del Rio A; Evert M; Kannengiesser S; Völzke H; Mensel B; Puls R; Hosten N; Reeder SB
    Radiology; 2012 Oct; 265(1):133-42. PubMed ID: 22923718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.
    Krafft AJ; Loeffler RB; Song R; Bian X; McCarville MB; Hankins JS; Hillenbrand CM
    Magn Reson Med; 2016 Aug; 76(2):591-601. PubMed ID: 26308155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.
    Price JC; Dodge JL; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski S; Tien PC
    AIDS; 2017 Sep; 31(15):2119-2125. PubMed ID: 28723710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-echo Dixon and breath-hold T2-corrected multi-echo single-voxel MRS for quantifying hepatic iron overload in rabbits.
    Zhao F; Chen Y; Zhang H; Li C; Long L
    Acta Radiol; 2023 Jan; 64(1):13-19. PubMed ID: 34904894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.
    Szurowska E; Sikorska K; Izycka-Swieszewska E; Nowicki T; Romanowski T; Bielawski KP; Studniarek M
    BMC Gastroenterol; 2010 Jan; 10():13. PubMed ID: 20105330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Spectroscopy in Living-Donor Liver Transplantation.
    Chiang HJ; Chang WP; Chiang HW; Lazo MZ; Chen TY; Ou HY; Tsang LL; Huang TL; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1003-6. PubMed ID: 27320542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of different Dixon-based methods for MR liver iron assessment in comparison to a biopsy-validated R2* relaxometry method.
    Henninger B; Plaikner M; Zoller H; Viveiros A; Kannengiesser S; Jaschke W; Kremser C
    Eur Radiol; 2021 Apr; 31(4):2252-2262. PubMed ID: 32965571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
    Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
    Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
    Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
    Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.